Patent ID: 9603815
Date: 2017-03-28
CPC Classifications: A61K,A61P,C12Q

Claim:
1. A method of treating seizures in a patient diagnosed with Dravet syndrome, comprising: administering to the patient diagnosed with Dravet Syndrome a therapeutically effective dose of a 5-HT2C agonist; administering an effective dose of stiripentol or a pharmaceutically acceptable salt thereof to said patient; administering an effective dose of valproate or a pharmaceutically acceptable salt thereof to said patient; administering an effective dose of clobazam or a pharmaceutically acceptable salt thereof to said patient; and allowing the 5-HT2C agonist to stimulate 5-HT2C receptors in the patient and thereby reduce seizures in the patient, wherein the 5-HT2C agonist is fenfluramine.